Earlier this week, Eli Lilly announced it broke ground on a large site in Houston, Texas. The location will be one of ten US ...

New ICER and West Health data show 2025 drug prices topping $250,000 as many patients struggle to access treatments ...

Molecular testing firm Qiagen has agreed to a $52.22-per-share all-cash acquisition by EQT Private Equity.

METiS TechBio has teamed up with Lilly in a deal worth $1.1bn, pairing AI-driven lipid design with pharma expertise to ...

BioXconomy highlights leading Black innovators and leaders in the biotechnology industry.

Germany’s Merck has agreed to acquire London-based Silence Therapeutics in an all-cash deal, adding a late-stage rare blood ...

The UK Medicines and Healthcare products Regulatory Agency will develop an AI protocol checker to help clinical trial sponsors.

IQVIA and Veeva extend their partnership, expanding sponsor access to Veeva's clinical trial and data management technology.

Europe's clinical trial numbers have fallen 13.5% annually since 2013, with late-stage and non-commercial trials declining.

The clinical-stage biotech has closed an oversubscribed Series D financing round in a bid to meeting its mission to stop ...

Estuary Biotherapeutics launches with $103 million to take gene therapies for kidney disease into the clinic. The financing ...

Dan is currently a trade media relations expert at Sartorius, a life science research and biopharmaceutical technology provider. He formerly led the news domain of Bioprocess International. He has ...